Local News: Cambodia 

 | 

Sign Up

 | 

Sign In

Advertisment

Sonata, Zaleplon

Sonata, Zaleplon News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make Sonata, Zaleplon News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

Sonata, Zaleplon News

News on Sonata, Zaleplon (generic) continually updated from thousands of sources around the net.

Tuesday Dec 1 | The Biotech Stock Blog

Somaxon Pharmaceuticals: FDA Close to a Decision for Silenor

The FDA will complete its review and provide an action letter to Somaxon Pharmaceuticals relating to the Silenor NDA by December 4, 2009.

Comment?

Related Topix: Food and Drug Administration, Biotech, Somaxon Pharmaceuticals, Medicine, Insomnia, Health, Sleep, Ambien, Zolpidem (generic), Medication

Thu Oct 22, 2009

Minyanville

Sex, Drugs, and the Rocky Economy: Drugs

Asked to name the most recession-resistant commodities, most people would place "drugs" in the top spot.

Comment?

Related Topix: Drugs, Medicine, Insomnia, Health, Biotech, SanofiSynthlabo, Ambien, Zolpidem (generic), Medication, Sepracor, Healthcare Industry

Sun Sep 20, 2009

Domain-B

Orchid receives USFDA approval for Zaleplon capsules

Orchid Chemicals & Pharmaceuticals has received approval from the US Food and Drug Administration for its abbreviated new drug application for Zaleplon capsules, 5mg and 10mg.

Comment?

Related Topix: Medicine, Medication, Food and Drug Administration, Insomnia, Health

Sat Sep 19, 2009

India Gazette

Natco Pharma launches anti-swine flu medicine

Drug maker Natco Pharma Friday said it has launched anti-swine flu drug Natflu. The maximum retail price of the medicine is fixed at Rs.480 for a bottle of 10 capsules and is available in all licensed pharmacies, the company said in a regulatory statement.

Comment?

Related Topix: H1N1 Influenza / Swine Flu, Health, Medicine, Medication

Thu Jun 11, 2009

Drugs.com

Presented at SLEEP 2009: New Controlled-Release Formulations of...

Jun 8, 2009 - Research sponsored by Somnus Therapeutics, Inc. demonstrates that new controlled-release formulations of a marketed insomnia medication have shown a pharmacodynamic profile indicative of a potential therapy that could address a frequent complaint of insomnia sufferers: preventing middle-of-the-night awakening without next-morning ...

Comment?

Related Topix: Medicine, Insomnia, Health, Medication

Fri Jun 05, 2009

New York Times

A Cost-Effective Good Night's Sleep

How much would you pay for a good night's sleep? If the sleep peddlers have their way, quite a bit.

Comment?

Related Topix: Sleep, Medicine, Health, Insomnia, Tampa Metro, Ambien, Zolpidem (generic), Medication, Business News

Also on Topix